Danazol is an effective agent for the prophylaxis of the recurrent attacks of mucocutaneous and visceral swelling which occur in patients with hereditary angioedema (HAE). Danazol apparently increases the synthesis of the inhibitor of the first component of complement which is partially deficient in these heterozygous individuals. The efficacy of danazol in this condition appears to be limited only by the occurrence of adverse effects.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Frank, M.M.: Complement; in Current Concepts. Scope Monograph, The Upjohn Company, pp. 1–48 (1975).
Frank, M.M.; Gelfand, J.A. and Atkinson, J.P.: Hereditary angioedema: the clinical syndrome and its management. Annals of Internal Medicine 84: 580–593 (1976).
Gelfand, J.A.; Sherins, R.J.; Alling, D.W. and Frank, M.M.: Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. New England Journal of Medicine 295: 1444–1448 (1976).
Hosea, S.W.; Santaella, M. and Frank, M.M.: Long term therapy of hereditary angioedema with danazol. Manuscript in preparation.
Jaffe, C.J.; Atkinson, J.P.; Gelfand, J.A. and Frank, M.M.: Hereditary angioedema: The use of fresh frozen plasma for prophylaxis in patients undergoing oral surgery. Journal of Allergy and Clinical Immunology 55: 386–393 (1975).
Spaulding, W.B.: Methyltestosterone therapy for hereditary episodal edema. Annals of Internal Medicine 53: 739–745 (1960).
About this article
Cite this article
Hosea, S.W., Frank, M.M. Danazol in the Treatment of Hereditary Angioedema. Drugs 19, 370–372 (1980). https://doi.org/10.2165/00003495-198019050-00007
- Fresh Freeze Plasma
- Hereditary Angioedema
- Birth Control Pill